BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11123277)

  • 1. Annexin V binds to positively selected B cells.
    Dillon SR; Constantinescu A; Schlissel MS
    J Immunol; 2001 Jan; 166(1):58-71. PubMed ID: 11123277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation.
    Dillon SR; Mancini M; Rosen A; Schlissel MS
    J Immunol; 2000 Feb; 164(3):1322-32. PubMed ID: 10640746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD28 by bone marrow stromal cells and its involvement in B lymphopoiesis.
    Gray Parkin K; Stephan RP; Apilado RG; Lill-Elghanian DA; Lee KP; Saha B; Witte PL
    J Immunol; 2002 Sep; 169(5):2292-302. PubMed ID: 12193694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells.
    Corcos D; Grandien A; Vazquez A; Dunda O; Lorès P; Bucchini D
    J Immunol; 2001 Mar; 166(5):3083-9. PubMed ID: 11207259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
    Heltemes-Harris L; Liu X; Manser T
    J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of a novel cellular constituent of the bone marrow that regulates the response of immature B cells to B cell antigen receptor engagement.
    Sandel PC; Gendelman M; Kelsoe G; Monroe JG
    J Immunol; 2001 May; 166(10):5935-44. PubMed ID: 11342608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxin.
    Goodyear CS; Narita M; Silverman GJ
    J Immunol; 2004 Mar; 172(5):2870-7. PubMed ID: 14978088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. 1991.
    Hardy RR; Carmack CE; Shinton SA; Kemp JD; Hayakawa K
    J Immunol; 2012 Oct; 189(7):3271-83. PubMed ID: 22997230
    [No Abstract]   [Full Text] [Related]  

  • 9. Normal cellular prion protein is preferentially expressed on subpopulations of murine hemopoietic cells.
    Liu T; Li R; Wong BS; Liu D; Pan T; Petersen RB; Gambetti P; Sy MS
    J Immunol; 2001 Mar; 166(6):3733-42. PubMed ID: 11238614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.
    Kenny JJ; Rezanka LJ; Lustig A; Fischer RT; Yoder J; Marshall S; Longo DL
    J Immunol; 2000 Apr; 164(8):4111-9. PubMed ID: 10754305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice.
    Stolp J; Mariño E; Batten M; Sierro F; Cox SL; Grey ST; Silveira PA
    J Immunol; 2013 Jul; 191(1):97-109. PubMed ID: 23740954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia.
    Marchbank KJ; Kulik L; Gipson MG; Morgan BP; Holers VM
    J Immunol; 2002 Oct; 169(7):3526-35. PubMed ID: 12244142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common pathway for dendritic cell and early B cell development.
    Izon D; Rudd K; DeMuth W; Pear WS; Clendenin C; Lindsley RC; Allman D
    J Immunol; 2001 Aug; 167(3):1387-92. PubMed ID: 11466357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Architectural defects in the spleens of Nkx2-3-deficient mice are intrinsic and associated with defects in both B cell maturation and T cell-dependent immune responses.
    Tarlinton D; Light A; Metcalf D; Harvey RP; Robb L
    J Immunol; 2003 Apr; 170(8):4002-10. PubMed ID: 12682228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell receptor affinity and B cell subset identity integrate to define the effectiveness, affinity threshold, and mechanism of anergy.
    Diz R; McCray SK; Clarke SH
    J Immunol; 2008 Sep; 181(6):3834-40. PubMed ID: 18768837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells.
    Snyder CM; Zhang X; Wysocki LJ
    J Immunol; 2002 Apr; 168(8):3865-73. PubMed ID: 11937540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells.
    Oliver AM; Martin F; Kearney JF
    J Immunol; 1999 Jun; 162(12):7198-207. PubMed ID: 10358166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo administration of the recombinant IL-7/hepatocyte growth factor β hybrid cytokine efficiently restores thymopoiesis and naive T cell generation in lethally irradiated mice after syngeneic bone marrow transplantation.
    Jin J; Goldschneider I; Lai L
    J Immunol; 2011 Feb; 186(4):1915-22. PubMed ID: 21209281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive immune responses are dispensable for isolated lymphoid follicle formation: antigen-naive, lymphotoxin-sufficient B lymphocytes drive the formation of mature isolated lymphoid follicles.
    McDonald KG; McDonough JS; Newberry RD
    J Immunol; 2005 May; 174(9):5720-8. PubMed ID: 15843574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid induction of splenic and peritoneal B-1a cells in adult mice by thymus-independent type-2 antigen.
    Whitmore AC; Neely HR; Diz R; Flood PM
    J Immunol; 2004 Nov; 173(9):5406-14. PubMed ID: 15494487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.